scholarly journals Initiation of acute graft-versus-host disease by angiogenesis

Blood ◽  
2017 ◽  
Vol 129 (14) ◽  
pp. 2021-2032 ◽  
Author(s):  
Katarina Riesner ◽  
Yu Shi ◽  
Angela Jacobi ◽  
Martin Kräter ◽  
Martina Kalupa ◽  
...  

Key Points Angiogenesis preceded infiltration of inflammatory leukocytes during GVHD as well as during experimental colitis. Metabolic alterations and cytoskeleton changes occurred during early angiogenesis, but classical endothelial activation signs were absent.

Blood ◽  
2017 ◽  
Vol 129 (24) ◽  
pp. 3256-3261 ◽  
Author(s):  
Yi-Bin Chen ◽  
Miguel-Angel Perales ◽  
Shuli Li ◽  
Maria Kempner ◽  
Carol Reynolds ◽  
...  

Key Points BV has activity for SR-aGVHD. The MTD of BV was 0.8 mg/kg every 2 weeks for 4 doses.


2019 ◽  
Vol 3 (23) ◽  
pp. 4034-4042 ◽  
Author(s):  
Hrishikesh K. Srinagesh ◽  
Umut Özbek ◽  
Urvi Kapoor ◽  
Francis Ayuk ◽  
Mina Aziz ◽  
...  

Key Points The MAGIC algorithm probability, computed from 2 serum biomarkers, predicts mortality in all GVHD grades after 4 weeks of treatment. Dynamic changes in the MAGIC algorithm probability occur within all biomarker risk groups and can guide therapy.


Blood ◽  
2014 ◽  
Vol 124 (2) ◽  
pp. 287-295 ◽  
Author(s):  
Mohamed L. Sorror ◽  
Paul J. Martin ◽  
Rainer F. Storb ◽  
Smita Bhatia ◽  
Richard T. Maziarz ◽  
...  

Key Points The HCT-CI stratifies patients into 3 groups for risks of grades 3 to 4 GVHD regardless of conditioning intensity, donor, or graft types. Comorbidity burden and development of grades 2 to 4 acute GVHD have cumulative effects on mortality rates.


Blood ◽  
2018 ◽  
Vol 131 (12) ◽  
pp. 1372-1379 ◽  
Author(s):  
John M. Magenau ◽  
Steven C. Goldstein ◽  
Dan Peltier ◽  
Robert J. Soiffer ◽  
Thomas Braun ◽  
...  

Key PointsAAT infusion produced a high proportion of durable clinical responses in SR-aGVHD. AAT is associated with minimal toxicity and low rates of infection in patients with SR-aGVHD at significant risk for mortality.


Blood ◽  
2013 ◽  
Vol 122 (10) ◽  
pp. 1802-1812 ◽  
Author(s):  
Shen Dong ◽  
Sylvie Maiella ◽  
Aliénor Xhaard ◽  
Yuanyu Pang ◽  
Lynn Wenandy ◽  
...  

Key Points Single-cell heterogeneity, rather than lineage reprogramming, explains the remarkable complexity and functional diversity of human Tregs. Altered homeostasis of Treg subpopulations in patients developing acute graft-versus-host disease.


Blood ◽  
2013 ◽  
Vol 122 (19) ◽  
pp. 3365-3375 ◽  
Author(s):  
Bin Xiao ◽  
Yu Wang ◽  
Wei Li ◽  
Megan Baker ◽  
Jian Guo ◽  
...  

Key Points Identification of a miRNA panel as a biomarker for the diagnosis, prognosis, and prediction of acute graft-versus-host disease.


2018 ◽  
Vol 2 (15) ◽  
pp. 1882-1888 ◽  
Author(s):  
Shernan G. Holtan ◽  
Todd E. DeFor ◽  
Angela Panoskaltsis-Mortari ◽  
Nandita Khera ◽  
John E. Levine ◽  
...  

Key Points High-circulating AREG (≥33 pg/mL) reclassifies additional patients into HR categories and further refines the Minnesota aGVHD risk score. Patients with aGVHD and AREG ≥33 pg/mL have lower rates of steroid response, higher NRM, and poorer OS.


Blood ◽  
2017 ◽  
Vol 129 (15) ◽  
pp. 2172-2185 ◽  
Author(s):  
Antiopi Varelias ◽  
Kate L. Ormerod ◽  
Mark D. Bunting ◽  
Motoko Koyama ◽  
Kate H. Gartlan ◽  
...  

Key PointsRecipient-derived IL-17A is critical for the prevention of intestinal acute GVHD. Increased susceptibility to acute GVHD can be transferred to WT mice via cohousing with IL-17RA or IL-17RC–deficient mice.


Blood ◽  
2015 ◽  
Vol 125 (1) ◽  
pp. 199-205 ◽  
Author(s):  
Doris M. Ponce ◽  
Patrick Hilden ◽  
Christen Mumaw ◽  
Sean M. Devlin ◽  
Marissa Lubin ◽  
...  

Key Points ST2 is independently associated with aGVHD after day 28 in cord blood transplantation recipients. High ST2 levels predict for increased TRM in cord blood transplantation recipients.


Sign in / Sign up

Export Citation Format

Share Document